Como international conference position statement: lung cancer screening for early diagnosis 5 years after the 1998 Varese conference
Lung cancer is the most common cause of cancer death in the world. Nonetheless, public policy organizations have consistently recommended against screening for lung cancer, with the result that screening is not widely practiced. The Como Conference was undertaken to consider the need for a change in...
Gespeichert in:
| Veröffentlicht in: | Chest 2005-04, Vol.127 (4), p.1146-1151 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1151 |
|---|---|
| container_issue | 4 |
| container_start_page | 1146 |
| container_title | Chest |
| container_volume | 127 |
| creator | Strauss, Gary M Dominioni, Lorenzo Jett, James R Freedman, Matthew Grannis, Jr, Frederic W |
| description | Lung cancer is the most common cause of cancer death in the world. Nonetheless, public policy organizations have consistently recommended against screening for lung cancer, with the result that screening is not widely practiced. The Como Conference was undertaken to consider the need for a change in the existing recommendations against screening.
The primary objective of the Como Conference was to consider whether there is sufficient scientific evidence to advise screening for lung cancer among asymptomatic individuals outside the context of a clinical trial. Methodological issues that are relevant to the proper interpretation of early detection trials were carefully considered. Advantages and problems associated with technological advances in CT scans and digital chest radiographs (CXRs) were fully explored. Economic issues relevant to screening were also considered.
It is recommended that physicians assume responsibility for informing high-risk individuals regarding options for screening for lung cancer. Targeted high-risk individuals include middle-aged or elderly men and women who are current or former cigarette smokers of > 20 to 30 pack-years without serious medical comorbidities. It is recommended that such persons be informed that symptomatic lung cancer is usually advanced and incurable, while surgery for early lung cancer offers a far better chance of cure. They should also be informed about advances in imaging technology, as they relate to CT scans and CXRs.
Whenever possible, high-risk individuals should be encouraged to enroll in ongoing trials. For subjects who, though eligible, do not have access to such trials, a process of shared decision-making between physicians and at-risk individuals is strongly recommended. After discussion of the existing state of knowledge, high-risk individuals should be made aware that it is reasonable for them to choose to undergo testing for lung cancer. |
| doi_str_mv | 10.1378/chest.127.4.1146 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_67728070</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A132002122</galeid><sourcerecordid>A132002122</sourcerecordid><originalsourceid>FETCH-LOGICAL-c354t-1f3e340a1cfb1b63a893416a5a65108a788f8b5a77e892c84d43a0021628f8643</originalsourceid><addsrcrecordid>eNptkc2PFCEQxYnRuOPq3ZMhHrx1SwHdTXvbTPxKNvGiXkkNU8yy6YYReg5z3z9cxplEYzYcCK9-ryh4jL0G0YIazHt3R2VpQQ6tbgF0_4StYFTQqE6rp2wlBMhG9aO8Yi9KuRf1DGP_nF1BZySAMSv2sE5z4iEulCMuIUWcuEvRU6boiO9TCSeVlwUXmikuH_h0iDvusJYzLy4TxVAFnzInzNORbwPuYvUV3vFjlQpHX9vz5Y44jKPhPzFToX-uecmeeZwKvbrs1-zHp4_f11-a22-fv65vbhtXH7Q04BUpLRCc38CmV2hGpaHHDvsOhMHBGG82HQ4DmVE6o7daoRASelkLvVbX7N257z6nX4f6dXYOxdE0YaR0KLYfBmnEICr49j_wPh3qB03FSiH0IHSvKtScoR1OZEP0acnodhQp45Qi-VDlG1DyNIKUlW8f4eva0hzcowZxNricSsnk7T6HGfPRgrCn_O2f_G3N32p7yr9a3lwGP2xm2v41XAJXvwEfU6vC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>200470463</pqid></control><display><type>article</type><title>Como international conference position statement: lung cancer screening for early diagnosis 5 years after the 1998 Varese conference</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Strauss, Gary M ; Dominioni, Lorenzo ; Jett, James R ; Freedman, Matthew ; Grannis, Jr, Frederic W</creator><creatorcontrib>Strauss, Gary M ; Dominioni, Lorenzo ; Jett, James R ; Freedman, Matthew ; Grannis, Jr, Frederic W</creatorcontrib><description>Lung cancer is the most common cause of cancer death in the world. Nonetheless, public policy organizations have consistently recommended against screening for lung cancer, with the result that screening is not widely practiced. The Como Conference was undertaken to consider the need for a change in the existing recommendations against screening.
The primary objective of the Como Conference was to consider whether there is sufficient scientific evidence to advise screening for lung cancer among asymptomatic individuals outside the context of a clinical trial. Methodological issues that are relevant to the proper interpretation of early detection trials were carefully considered. Advantages and problems associated with technological advances in CT scans and digital chest radiographs (CXRs) were fully explored. Economic issues relevant to screening were also considered.
It is recommended that physicians assume responsibility for informing high-risk individuals regarding options for screening for lung cancer. Targeted high-risk individuals include middle-aged or elderly men and women who are current or former cigarette smokers of > 20 to 30 pack-years without serious medical comorbidities. It is recommended that such persons be informed that symptomatic lung cancer is usually advanced and incurable, while surgery for early lung cancer offers a far better chance of cure. They should also be informed about advances in imaging technology, as they relate to CT scans and CXRs.
Whenever possible, high-risk individuals should be encouraged to enroll in ongoing trials. For subjects who, though eligible, do not have access to such trials, a process of shared decision-making between physicians and at-risk individuals is strongly recommended. After discussion of the existing state of knowledge, high-risk individuals should be made aware that it is reasonable for them to choose to undergo testing for lung cancer.</description><identifier>ISSN: 0012-3692</identifier><identifier>EISSN: 1931-3543</identifier><identifier>DOI: 10.1378/chest.127.4.1146</identifier><identifier>PMID: 15821188</identifier><identifier>CODEN: CHETBF</identifier><language>eng</language><publisher>United States: Elsevier B.V</publisher><subject>Cancer ; Care and treatment ; Congresses as Topic ; Diagnosis ; Early Diagnosis ; Humans ; Lung cancer ; Lung Neoplasms - diagnosis ; Mass Screening ; Mortality ; Practice Guidelines as Topic ; Risk factors ; Smoking ; Time Factors ; United States</subject><ispartof>Chest, 2005-04, Vol.127 (4), p.1146-1151</ispartof><rights>COPYRIGHT 2005 Elsevier B.V.</rights><rights>Copyright American College of Chest Physicians Apr 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15821188$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Strauss, Gary M</creatorcontrib><creatorcontrib>Dominioni, Lorenzo</creatorcontrib><creatorcontrib>Jett, James R</creatorcontrib><creatorcontrib>Freedman, Matthew</creatorcontrib><creatorcontrib>Grannis, Jr, Frederic W</creatorcontrib><title>Como international conference position statement: lung cancer screening for early diagnosis 5 years after the 1998 Varese conference</title><title>Chest</title><addtitle>Chest</addtitle><description>Lung cancer is the most common cause of cancer death in the world. Nonetheless, public policy organizations have consistently recommended against screening for lung cancer, with the result that screening is not widely practiced. The Como Conference was undertaken to consider the need for a change in the existing recommendations against screening.
The primary objective of the Como Conference was to consider whether there is sufficient scientific evidence to advise screening for lung cancer among asymptomatic individuals outside the context of a clinical trial. Methodological issues that are relevant to the proper interpretation of early detection trials were carefully considered. Advantages and problems associated with technological advances in CT scans and digital chest radiographs (CXRs) were fully explored. Economic issues relevant to screening were also considered.
It is recommended that physicians assume responsibility for informing high-risk individuals regarding options for screening for lung cancer. Targeted high-risk individuals include middle-aged or elderly men and women who are current or former cigarette smokers of > 20 to 30 pack-years without serious medical comorbidities. It is recommended that such persons be informed that symptomatic lung cancer is usually advanced and incurable, while surgery for early lung cancer offers a far better chance of cure. They should also be informed about advances in imaging technology, as they relate to CT scans and CXRs.
Whenever possible, high-risk individuals should be encouraged to enroll in ongoing trials. For subjects who, though eligible, do not have access to such trials, a process of shared decision-making between physicians and at-risk individuals is strongly recommended. After discussion of the existing state of knowledge, high-risk individuals should be made aware that it is reasonable for them to choose to undergo testing for lung cancer.</description><subject>Cancer</subject><subject>Care and treatment</subject><subject>Congresses as Topic</subject><subject>Diagnosis</subject><subject>Early Diagnosis</subject><subject>Humans</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - diagnosis</subject><subject>Mass Screening</subject><subject>Mortality</subject><subject>Practice Guidelines as Topic</subject><subject>Risk factors</subject><subject>Smoking</subject><subject>Time Factors</subject><subject>United States</subject><issn>0012-3692</issn><issn>1931-3543</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptkc2PFCEQxYnRuOPq3ZMhHrx1SwHdTXvbTPxKNvGiXkkNU8yy6YYReg5z3z9cxplEYzYcCK9-ryh4jL0G0YIazHt3R2VpQQ6tbgF0_4StYFTQqE6rp2wlBMhG9aO8Yi9KuRf1DGP_nF1BZySAMSv2sE5z4iEulCMuIUWcuEvRU6boiO9TCSeVlwUXmikuH_h0iDvusJYzLy4TxVAFnzInzNORbwPuYvUV3vFjlQpHX9vz5Y44jKPhPzFToX-uecmeeZwKvbrs1-zHp4_f11-a22-fv65vbhtXH7Q04BUpLRCc38CmV2hGpaHHDvsOhMHBGG82HQ4DmVE6o7daoRASelkLvVbX7N257z6nX4f6dXYOxdE0YaR0KLYfBmnEICr49j_wPh3qB03FSiH0IHSvKtScoR1OZEP0acnodhQp45Qi-VDlG1DyNIKUlW8f4eva0hzcowZxNricSsnk7T6HGfPRgrCn_O2f_G3N32p7yr9a3lwGP2xm2v41XAJXvwEfU6vC</recordid><startdate>20050401</startdate><enddate>20050401</enddate><creator>Strauss, Gary M</creator><creator>Dominioni, Lorenzo</creator><creator>Jett, James R</creator><creator>Freedman, Matthew</creator><creator>Grannis, Jr, Frederic W</creator><general>Elsevier B.V</general><general>American College of Chest Physicians</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20050401</creationdate><title>Como international conference position statement: lung cancer screening for early diagnosis 5 years after the 1998 Varese conference</title><author>Strauss, Gary M ; Dominioni, Lorenzo ; Jett, James R ; Freedman, Matthew ; Grannis, Jr, Frederic W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c354t-1f3e340a1cfb1b63a893416a5a65108a788f8b5a77e892c84d43a0021628f8643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Cancer</topic><topic>Care and treatment</topic><topic>Congresses as Topic</topic><topic>Diagnosis</topic><topic>Early Diagnosis</topic><topic>Humans</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - diagnosis</topic><topic>Mass Screening</topic><topic>Mortality</topic><topic>Practice Guidelines as Topic</topic><topic>Risk factors</topic><topic>Smoking</topic><topic>Time Factors</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Strauss, Gary M</creatorcontrib><creatorcontrib>Dominioni, Lorenzo</creatorcontrib><creatorcontrib>Jett, James R</creatorcontrib><creatorcontrib>Freedman, Matthew</creatorcontrib><creatorcontrib>Grannis, Jr, Frederic W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Chest</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Strauss, Gary M</au><au>Dominioni, Lorenzo</au><au>Jett, James R</au><au>Freedman, Matthew</au><au>Grannis, Jr, Frederic W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Como international conference position statement: lung cancer screening for early diagnosis 5 years after the 1998 Varese conference</atitle><jtitle>Chest</jtitle><addtitle>Chest</addtitle><date>2005-04-01</date><risdate>2005</risdate><volume>127</volume><issue>4</issue><spage>1146</spage><epage>1151</epage><pages>1146-1151</pages><issn>0012-3692</issn><eissn>1931-3543</eissn><coden>CHETBF</coden><abstract>Lung cancer is the most common cause of cancer death in the world. Nonetheless, public policy organizations have consistently recommended against screening for lung cancer, with the result that screening is not widely practiced. The Como Conference was undertaken to consider the need for a change in the existing recommendations against screening.
The primary objective of the Como Conference was to consider whether there is sufficient scientific evidence to advise screening for lung cancer among asymptomatic individuals outside the context of a clinical trial. Methodological issues that are relevant to the proper interpretation of early detection trials were carefully considered. Advantages and problems associated with technological advances in CT scans and digital chest radiographs (CXRs) were fully explored. Economic issues relevant to screening were also considered.
It is recommended that physicians assume responsibility for informing high-risk individuals regarding options for screening for lung cancer. Targeted high-risk individuals include middle-aged or elderly men and women who are current or former cigarette smokers of > 20 to 30 pack-years without serious medical comorbidities. It is recommended that such persons be informed that symptomatic lung cancer is usually advanced and incurable, while surgery for early lung cancer offers a far better chance of cure. They should also be informed about advances in imaging technology, as they relate to CT scans and CXRs.
Whenever possible, high-risk individuals should be encouraged to enroll in ongoing trials. For subjects who, though eligible, do not have access to such trials, a process of shared decision-making between physicians and at-risk individuals is strongly recommended. After discussion of the existing state of knowledge, high-risk individuals should be made aware that it is reasonable for them to choose to undergo testing for lung cancer.</abstract><cop>United States</cop><pub>Elsevier B.V</pub><pmid>15821188</pmid><doi>10.1378/chest.127.4.1146</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0012-3692 |
| ispartof | Chest, 2005-04, Vol.127 (4), p.1146-1151 |
| issn | 0012-3692 1931-3543 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67728070 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Cancer Care and treatment Congresses as Topic Diagnosis Early Diagnosis Humans Lung cancer Lung Neoplasms - diagnosis Mass Screening Mortality Practice Guidelines as Topic Risk factors Smoking Time Factors United States |
| title | Como international conference position statement: lung cancer screening for early diagnosis 5 years after the 1998 Varese conference |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T13%3A33%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Como%20international%20conference%20position%20statement:%20lung%20cancer%20screening%20for%20early%20diagnosis%205%20years%20after%20the%201998%20Varese%20conference&rft.jtitle=Chest&rft.au=Strauss,%20Gary%20M&rft.date=2005-04-01&rft.volume=127&rft.issue=4&rft.spage=1146&rft.epage=1151&rft.pages=1146-1151&rft.issn=0012-3692&rft.eissn=1931-3543&rft.coden=CHETBF&rft_id=info:doi/10.1378/chest.127.4.1146&rft_dat=%3Cgale_proqu%3EA132002122%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=200470463&rft_id=info:pmid/15821188&rft_galeid=A132002122&rfr_iscdi=true |